רווח למניה בשנים עשר החודשים האחרונים: DarioHealth Corp (DRIO)

DarioHealth Corp. possesses strong pricing power driven by its AI-powered hypertension and diabetes management system. A snapshot of the rolling net income per share visualizes these processes, with the indicator value reaching -5.16. The company generates revenue through subscriptions from insurers and patients. Business scaling via corporate contracts is currently constrained only by marketing expenses and software integration costs.

DarioHealth Corp. (DRIO) is scaling its digital platform, overcoming temporary integration costs within the insurance sector. The TTM EPS reflects net income allocated per share over a rolling year. This metric allows for an assessment of real capital efficiency net of all expenses. Growth in earnings per share confirms the operational leverage of the software. By analyzing the EPS trend over the last 12 months, an investor can identify the gap between the asset's value and its yield.